Cargando…
Reversal of mcr-1-Mediated Colistin Resistance in Escherichia coli by CRISPR-Cas9 System
PURPOSE: The plasmid-borne mobilized colistin resistance gene (mcr-1) was discovered in 2015. Subsequently, the rapid horizontal transfer of mcr-1 gene to diverse bacterial species poses a serious threat to public health, which urgently needs the introduction of novel antimicrobial strategies. There...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7184118/ https://www.ncbi.nlm.nih.gov/pubmed/32368108 http://dx.doi.org/10.2147/IDR.S244885 |
_version_ | 1783526555563065344 |
---|---|
author | Wan, Peng Cui, Shiyun Ma, Zhenbao Chen, Lin Li, Xiaoshen Zhao, Ruonan Xiong, Wenguang Zeng, Zhenling |
author_facet | Wan, Peng Cui, Shiyun Ma, Zhenbao Chen, Lin Li, Xiaoshen Zhao, Ruonan Xiong, Wenguang Zeng, Zhenling |
author_sort | Wan, Peng |
collection | PubMed |
description | PURPOSE: The plasmid-borne mobilized colistin resistance gene (mcr-1) was discovered in 2015. Subsequently, the rapid horizontal transfer of mcr-1 gene to diverse bacterial species poses a serious threat to public health, which urgently needs the introduction of novel antimicrobial strategies. Therefore, the purpose of this study is to sensitize bacteria to colistin and reduce the propagation of mcr-1 gene by curing mcr-1-harboring plasmid in Escherichia coli (E. coli) using the CRISPR-Cas9 system. METHODS: Two sgRNAs specific to mcr-1 gene were designed and cloned into plasmid pCas9. The recombinant plasmid pCas9-mcr was transformed into E. coli carrying pUC19-mcr-1 or pHNSHP45, separately. The elimination efficiency in strains was evaluated by PCR and quantitative real-time PCR (qPCR). The antimicrobial susceptibility test was performed using the broth microdilution method. RESULTS: In this study, we constructed the high copy number plasmid pUC19-mcr-1 and recombinant plasmid pCas9-m1 or pCas9-m2, which contain 20 nt or 30 nt sgRNA sequences targeted to mcr-1, respectively. PCR and qPCR results showed that mcr-1-harboring plasmids could be efficiently eliminated, and there was no significant correlation between sgRNA lengths and curing efficiency. However, when comparing restructured high copy number plasmid (pUC19-mcr-1) to natural resistance plasmid (pHNSHP45) in eliminating efficiency, we found that the content of plasmid backbone had an influence on efficiency. Furthermore, the conjugation assays verified that the engineered CRISPR-Cas9 system in bacteria or in bacteria genome can protect the recipient from plasmid-borne mcr-1 transfer via conjugation. Additionally, sequence analysis showed that three different types of defects in CRISPR-Cas9 system lead to escape mutants. CONCLUSION: We presented a method that only one plasmid-mediated CRISPR-Cas9 system can be used to efficiently resensitize E. coli to colistin. Moreover, this system provided a great potentiality to counteract the propagation of mcr-1 among bacterial pathogens. |
format | Online Article Text |
id | pubmed-7184118 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-71841182020-05-04 Reversal of mcr-1-Mediated Colistin Resistance in Escherichia coli by CRISPR-Cas9 System Wan, Peng Cui, Shiyun Ma, Zhenbao Chen, Lin Li, Xiaoshen Zhao, Ruonan Xiong, Wenguang Zeng, Zhenling Infect Drug Resist Original Research PURPOSE: The plasmid-borne mobilized colistin resistance gene (mcr-1) was discovered in 2015. Subsequently, the rapid horizontal transfer of mcr-1 gene to diverse bacterial species poses a serious threat to public health, which urgently needs the introduction of novel antimicrobial strategies. Therefore, the purpose of this study is to sensitize bacteria to colistin and reduce the propagation of mcr-1 gene by curing mcr-1-harboring plasmid in Escherichia coli (E. coli) using the CRISPR-Cas9 system. METHODS: Two sgRNAs specific to mcr-1 gene were designed and cloned into plasmid pCas9. The recombinant plasmid pCas9-mcr was transformed into E. coli carrying pUC19-mcr-1 or pHNSHP45, separately. The elimination efficiency in strains was evaluated by PCR and quantitative real-time PCR (qPCR). The antimicrobial susceptibility test was performed using the broth microdilution method. RESULTS: In this study, we constructed the high copy number plasmid pUC19-mcr-1 and recombinant plasmid pCas9-m1 or pCas9-m2, which contain 20 nt or 30 nt sgRNA sequences targeted to mcr-1, respectively. PCR and qPCR results showed that mcr-1-harboring plasmids could be efficiently eliminated, and there was no significant correlation between sgRNA lengths and curing efficiency. However, when comparing restructured high copy number plasmid (pUC19-mcr-1) to natural resistance plasmid (pHNSHP45) in eliminating efficiency, we found that the content of plasmid backbone had an influence on efficiency. Furthermore, the conjugation assays verified that the engineered CRISPR-Cas9 system in bacteria or in bacteria genome can protect the recipient from plasmid-borne mcr-1 transfer via conjugation. Additionally, sequence analysis showed that three different types of defects in CRISPR-Cas9 system lead to escape mutants. CONCLUSION: We presented a method that only one plasmid-mediated CRISPR-Cas9 system can be used to efficiently resensitize E. coli to colistin. Moreover, this system provided a great potentiality to counteract the propagation of mcr-1 among bacterial pathogens. Dove 2020-04-22 /pmc/articles/PMC7184118/ /pubmed/32368108 http://dx.doi.org/10.2147/IDR.S244885 Text en © 2020 Wan et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Original Research Wan, Peng Cui, Shiyun Ma, Zhenbao Chen, Lin Li, Xiaoshen Zhao, Ruonan Xiong, Wenguang Zeng, Zhenling Reversal of mcr-1-Mediated Colistin Resistance in Escherichia coli by CRISPR-Cas9 System |
title | Reversal of mcr-1-Mediated Colistin Resistance in Escherichia coli by CRISPR-Cas9 System |
title_full | Reversal of mcr-1-Mediated Colistin Resistance in Escherichia coli by CRISPR-Cas9 System |
title_fullStr | Reversal of mcr-1-Mediated Colistin Resistance in Escherichia coli by CRISPR-Cas9 System |
title_full_unstemmed | Reversal of mcr-1-Mediated Colistin Resistance in Escherichia coli by CRISPR-Cas9 System |
title_short | Reversal of mcr-1-Mediated Colistin Resistance in Escherichia coli by CRISPR-Cas9 System |
title_sort | reversal of mcr-1-mediated colistin resistance in escherichia coli by crispr-cas9 system |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7184118/ https://www.ncbi.nlm.nih.gov/pubmed/32368108 http://dx.doi.org/10.2147/IDR.S244885 |
work_keys_str_mv | AT wanpeng reversalofmcr1mediatedcolistinresistanceinescherichiacolibycrisprcas9system AT cuishiyun reversalofmcr1mediatedcolistinresistanceinescherichiacolibycrisprcas9system AT mazhenbao reversalofmcr1mediatedcolistinresistanceinescherichiacolibycrisprcas9system AT chenlin reversalofmcr1mediatedcolistinresistanceinescherichiacolibycrisprcas9system AT lixiaoshen reversalofmcr1mediatedcolistinresistanceinescherichiacolibycrisprcas9system AT zhaoruonan reversalofmcr1mediatedcolistinresistanceinescherichiacolibycrisprcas9system AT xiongwenguang reversalofmcr1mediatedcolistinresistanceinescherichiacolibycrisprcas9system AT zengzhenling reversalofmcr1mediatedcolistinresistanceinescherichiacolibycrisprcas9system |